PROmyBETAappGame: a Study to Learn More About the Medication Usage & Patient Reported Outcomes Via the myBETAapp and to Find Out More About the Usage of Game Principles and Game Design Elements (Gamification) in Medical Care of Patients With Multiple Sclerosis Treated With Betaferon
What it found
We found no results in the registry or in papers.
This trial finished 6 years ago. We found no results in the registry or in any paper that cites it.
What was tested
Treatment tested
- myBETAapp
- PEAK
- Interferon beta-1b
Interferon alpha/beta receptor agonist
- BETACONNECT
What it measured
Main measures
Compliance percentage to therapy
Up to 12 months from informed consent provided
Persistence percentage of therapy
Up to 12 months from informed consent provided
Adherence percentage to therapy, assessed prospectively
Up to 12 months from informed consent provided
Quality of life (reported by participants)Absolute number of injections missed per 3-month intervals
Up to 12 months from informed consent provided
Relative proportion of injections missed per 3-month intervals
Up to 12 months from informed consent provided
Other measures (16)
Compliance percentage to therapy
Retrospective analysis from 01-Sep-2015 to 15-Apr-2019
Persistence percentage of therapy
Retrospective analysis from 01-Sep-2015 to 15-Apr-2019
Adherence percentage to therapy
Retrospective analysis from 01-Sep-2015 to 15-Apr-2019
Quality of life (reported by participants)Absolute number of injections missed per 3-month intervals
Retrospective analysis from 01-Sep-2015 to 15-Apr-2019
Relative proportion of injections missed per 3-month intervals
Retrospective analysis from 01-Sep-2015 to 15-Apr-2019
Health-related quality of life assessed by questionnaire EQ-5D-5L
Up to 12 months from informed consent provided
Walking and mobilityPainMood and sleepQuality of life (reported by participants)Scores of Treatment Satisfaction Questionnaire for Medication version 2 (TSQM v.II)
Up to 12 months from informed consent provided
Quality of life (reported by participants)Response level of Satisfaction with the BETAPLUS patient support program (service questionnaire)
Up to 12 months from informed consent provided
Quality of life (reported by participants)Response level of Satisfaction with the BETACONNECT autoinjector (service questionnaire)
Up to 12 months from informed consent provided
Quality of life (reported by participants)Response level of Satisfaction with the myBETAapp (service questionnaire)
Up to 12 months from informed consent provided
Quality of life (reported by participants)
Who could take part
MS (type not specified) · 18 and over
Inclusion criteria * Patients aged ≥ 18 years. * Patients on treatment with Betaferon (every Betaferon box contains a "Mixject" number, which is a product specific number unrelated to the study. Only patients prescribed Betaferon for their MS will be able to use the myBETAapp and participate in the study). * Patients must be using the myBETAapp. * Electronic informed consent must be obtained. Exclusion criteria - No exclusion criteria for participation in this study were defined.
As registered. Criteria can change, so ask the trial team or your neurologist.
About this trial
In the sponsor's words
In this study researchers wanted to learn more about the medication usage behavior among multiple sclerosis (MS) patients treated with Betaferon using the myBETAapp which includes the elements to what extent * taking medication matched the presciber´s recommendation (adherence, compliance), * treatment for the prescribed duration (persistence) was continued and * injections were missed. Among MS patients treated with Betaferon using the myBETAapp the study also collected information on the health-related quality of life, treatment satisfaction and satisfaction with treatment support.
Papers
Loading reviews and guidelines…
Related trials
- INFORM
Running, not recruiting
Still running
- Drug Repurposing Using Metformin for Improving the Therap…
Phase 2 · Status unknown
Missed its main goal
- US PROmyBETAapp2.0: A Study to Learn More About the Medic…
Completed
No result found
- EPID Multiple Sclerosis Pregnancy Study
Completed
No result found
- Comparison Study of PF530 and Betaferon in Healthy Subjects
Phase 1 · Completed
No result found
- Study to Evaluate the Pharmacokinetic Profiles of BIIB017…
Phase 1 · Completed
Result in a paper, not read yet
History
Started
Feb 2019
Main results due
Apr 2020
Finished
Sept 2020
Assembled by software from public sources and not checked by people. Each record links to its source. Report an error